Ebola surges in Democratic Republic of Congo as death toll surpasses 500 – THIS UPDATE

By Ayo Kehinde

The Democratic Republic of Congo (DRC) is grappling with a worsening Ebola outbreak after authorities confirmed the death toll surpassed 500, raising fears of further spread in the region as neighboring Uganda continues to record related infections.

The Congolese Ministry of Information announced Monday that the outbreak has so far resulted in 1,561 confirmed cases, including 506 deaths, underscoring the severity of the outbreak.

According to the ministry, 628 patients are currently undergoing treatment in designated hospitals and isolation centers, while 253 people have recovered from the disease.

The outbreak has also raised concerns among regional health authorities, with the Africa Centers for Disease Control and Prevention (Africa CDC) warning that containment efforts are being hampered by infected patients fleeing treatment and isolation facilities.

The agency said repeated incidents of Ebola-positive patients fleeing isolation centers have complicated contact tracing and increased the risk of community transmission, threatening to undermine efforts to contain the virus.

Health officials are also monitoring the cross-border impact of the outbreak. In neighboring Uganda, authorities have confirmed 19 Ebola infections, including two deaths, since the outbreak was first detected in May.

Ugandan health authorities have linked the infections to the ongoing outbreak in northeastern Democratic Republic of Congo, calling for stepped-up surveillance at border crossings and increased public health monitoring.

Ebola is a highly infectious viral hemorrhagic disease transmitted through direct contact with the blood or other body fluids of infected people, as well as contaminated objects.

Symptoms typically include sudden fever, fatigue, muscle pain, vomiting, diarrhea, and, in severe cases, internal and external bleeding.

The current outbreak is caused by the Bundibugyo strain of the Ebola virus, a variant that presents additional challenges because there is currently no licensed vaccine or specific antiviral treatment approved for it.

However, health experts say there is cautious optimism as two experimental antiviral therapies have entered clinical trials and are being evaluated for their effectiveness against the Bundibugyo variant.

The Democratic Republic of Congo has been hit by several Ebola epidemics in recent decades, drawing on extensive experience in responding to epidemics.

However, public health officials warn that the absence of an approved vaccine for the current strain, along with the flight of patients from treatment centers and the emergence of cross-border infections, could complicate efforts to bring the epidemic under control.

Regional and international health agencies continue to work with Congolese authorities to strengthen surveillance, improve case management, expand contact tracing and encourage communities to promptly report suspected infections as efforts to curb the spread of the deadly virus intensify.

Post views:
88